Orphan Medical’s Xyrem distributor

Express Scripts Specialty Distribution Services will be sole distributor for Orphan Medical cataplexy therapy Xyrem (sodium oxybate) as part of FDA's risk management program for the drug, a Schedule III controlled substance. Xyrem was approved July17 (1"The Pink Sheet" July 22, p. 14). Orphan Medical chose Express Scripts through open bid solicitation...